Yüklüyor......
Gemcitabine and carfilzomib induced thrombotic microangiopathy: eculizumab as a life‐saving treatment
Drug‐induced aHUS is rare; however, early diagnosis is vital to reduce morbidity and mortality. With confirmation of the diagnosis, eculizumab appears to be a viable treatment option to suppress the pro‐inflammatory surge. Furthermore, adverse side effects of medications such as carfilzomib and gemc...
Kaydedildi:
| Yayımlandı: | Clin Case Rep |
|---|---|
| Asıl Yazarlar: | , , , , , , , , , |
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
John Wiley and Sons Inc.
2017
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5715608/ https://ncbi.nlm.nih.gov/pubmed/29225827 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/ccr3.1214 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|